Plexison announced that the Food and Drug Administration (FDA) has approved Pleximmune, a first-in-class blood test to predict acute cellular rejection of transplanted livers and intestines in children.
A new study suggests that inflammation may be the driving force behind damage to blood vessels caused by elevated blood glucose levels, with the potential for the use of anti-inflammatory medications in reducing the risk of blood vessel disease in patients with diabetes.
Global Kinetics Corporation has announced that it has received marketing clearance for their Personal KinetiGraph (PKG), the first wrist-worn device approved in the U.S. to improve the assessment and monitoring of symptoms of Parkinson's disease and other neurological disorders that impact movement.
A Food and Drug Administration (FDA) Advisory Committee has voted in favor of recommending liraglutide for chronic weight management in individuals with obesity or who are overweight with at least one weight-related comorbidity
Hospira has announced a voluntary nationwide user-level recall of one lot of Heparin Sodium Injection due to a confirmed customer report of particulate in a single unit.